Concepedia

Luke Harris

LH

12

Publications

386

Citations

11

H-Index

1966

Active since

Affiliations

ImmunoGen (United States)(Current)

Janssen (United States)

Luke Harris is an author at ImmunoGen (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1966–2019

12

Publications

12

The inhibition of DNA synthesis by cannabinoids.

Richard A. Carchman, Luke Harris, Albert E. Munson · PubMed · 1976 · 70 citations

, , +17

A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody–Drug Conjugates (ADCs)

Michael L. Miller, Manami Shizuka, Alan Wilhelm et al. · Molecular Cancer Therapeutics · 2018 · 53 citations · Full text

Optimizing Lysosomal Activation of Antibody–Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers

Paulin Salomon, Emily E. Reid, Katie E. Archer et al. · Molecular Pharmaceutics · 2019 · 48 citations · Full text

Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity.

Sara Smith, Luke Harris, Ibrahim M. Uwaydah et al. · Journal of Pharmacology and Experimental Therapeutics · 1978 · 40 citations

Analgesic Antagonists. I. 4-Substituted 1-Acyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepines

Philip M. Carabateas, Luke Harris · Journal of Medicinal Chemistry · 1966 · 40 citations

, , +22

Rows per page

1–5 of 12